About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

FDA Approves Pfizer’s Anti-smoking Drug

by Medindia Content Team on May 12, 2006 at 4:41 PM
Font : A-A+

FDA Approves Pfizer’s Anti-smoking Drug

Pfizer's new drug, Chantix, which will help cigarette smokers to quit smoking, wins U.S. Food and Drug Administration's approval.

The active ingredient in Chantix is varenicline tartrate. The FDA gave chantix priority review based on the better effectiveness shown in preliminary trials compared to another anti-smoking drug known as zyban. Drugs receiving priority review get approved or rejected within six months while ordianry drugs get evaulated within ten months, reports foodconsumer.org.

Advertisement

Addiction to tobacco smoking is the number one harmful habit in the world. It is notoriously difficult for one to quit smoking since nicotine in the cigarette smoke binds to nicotinic receptors in the brain. These receptors in turn stimulate the reward pathway in brain circuitry. The activation of this pathway gives a pleasurable and contented feeling, which gradually transforms into a vicious cycle of craving and withdrawal.

Advertisement
Advertisement
Advertisement

Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

FDA Approves Pfizer’s Anti-smoking Drug Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests